Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

In the first two months of 2025, the number of reported cases of suspected hepatitis A infection increased sevenfold compared ...

Patients at emergency departments at Cambridgeshire hospitals will be screened for HIV, hepatitis B and hepatitis C under new ...

Still, a bout of hepatitis A can last weeks or months, and the worst cases can cause liver damage and even death. Since 1995, ...

Analysis of Global Burden of Disease 2021 data showed the overall burden of primary liver cancer in the US has increased over the past 2 decades.

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

On March 12, Florida Surgeon General Joseph Ladapo ordered the emergency restriction of Voepel's medical license. Voepel's ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.